These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22910892)

  • 1. Intravenous recombinant tissue-type plasminogen activator in the extended time window and the US Food and Drug Administration: confused about the time.
    Wechsler LR; Jovin TG
    Stroke; 2012 Sep; 43(9):2517-9. PubMed ID: 22910892
    [No Abstract]   [Full Text] [Related]  

  • 2. 4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly.
    Schellinger PD; Köhrmann M
    Stroke; 2014 Mar; 45(3):912-3. PubMed ID: 24526060
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolysis in the 3- to 4.5-hour window: what do ECASSkeptics want?
    Selim MH; Molina CA
    Stroke; 2014 Mar; 45(3):916-7. PubMed ID: 24526059
    [No Abstract]   [Full Text] [Related]  

  • 4. The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established.
    Wechsler LR
    Stroke; 2014 Mar; 45(3):914-5. PubMed ID: 24526061
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
    Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
    Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stroke care revolution.
    Lancet Neurol; 2015 Apr; 14(4):341. PubMed ID: 25752414
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating patients with ischemic stroke with tissue plasminogen activator in the 3.5- to 4-hour window: numbers support benefit but the message is to still go fast.
    Kurth T; Tzourio C
    Stroke; 2009 Jul; 40(7):2295-6. PubMed ID: 19498185
    [No Abstract]   [Full Text] [Related]  

  • 8. Further randomized controlled trials of tissue plasminogen activator within 3 hours are required.
    Lindley RI
    Stroke; 2001 Nov; 32(11):2708-9. PubMed ID: 11692040
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomised trials of endovascular treatment of stroke are needed.
    Ciccone A; Sterzi R
    Lancet Neurol; 2010 Jan; 9(1):30; author reply 31-2. PubMed ID: 20083033
    [No Abstract]   [Full Text] [Related]  

  • 10. European Cooperative Acute Stroke Study III: support for and questions about a truly emerging therapy.
    Fisher M; Hachinski V
    Stroke; 2009 Jun; 40(6):2262-3. PubMed ID: 19390068
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute stroke therapy: are we ready for primetime clinical trials?
    Kan P; Dumont TM; Levy EI; Siddiqui AH; Hopkins LN
    World Neurosurg; 2012; 77(5-6):596-7. PubMed ID: 22430324
    [No Abstract]   [Full Text] [Related]  

  • 12. 4.5 hours: the new time window for tissue plasminogen activator in stroke.
    Davis SM; Donnan GA
    Stroke; 2009 Jun; 40(6):2266-7. PubMed ID: 19407232
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised trials of endovascular treatment of stroke are needed.
    Schott AM
    Lancet Neurol; 2010 Jan; 9(1):30-1. PubMed ID: 20083032
    [No Abstract]   [Full Text] [Related]  

  • 14. Further randomized controlled trials of tPA within 3 hours are required-not!
    Lyden PD
    Stroke; 2001 Nov; 32(11):2709-10. PubMed ID: 11692041
    [No Abstract]   [Full Text] [Related]  

  • 15. When is enough enough?
    Donnan GA; Davis SM
    Stroke; 2001 Nov; 32(11):2710-1. PubMed ID: 11692042
    [No Abstract]   [Full Text] [Related]  

  • 16. IV and IA thrombolytic stroke strategies are complementary.
    Donnan GA; Davis SM
    Stroke; 2009 Jul; 40(7):2615. PubMed ID: 19443794
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous alteplase for ischaemic stroke.
    Albers GW; Olivot JM
    Lancet; 2007 Jan; 369(9558):249-50. PubMed ID: 17258646
    [No Abstract]   [Full Text] [Related]  

  • 18. Adding to the effectiveness of intravenous tissue plasminogen activator for treating acute stroke.
    Grotta JC
    Circulation; 2003 Jun; 107(22):2769-70. PubMed ID: 12796412
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
    Jahan R; Vinuela F
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is intraarterial tPA within 3 hours the treatment of choice for selected stroke patients?: No.
    Lindley RI
    Stroke; 2009 Jul; 40(7):2613-4. PubMed ID: 19443793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.